About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ucp2tm2.1Lowl
targeted mutation 2.1, Bradford B Lowell
MGI:4887236
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Pmch-cre)1Lowl/0
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB/NJ MGI:4887239
cn2
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/?
Tg(Pmch-cre)1Lowl/0
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/NJ MGI:4887257


Genotype
MGI:4887239
cn1
Allelic
Composition
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Pmch-cre)1Lowl/0
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB/NJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(CAG-Bgeo/GFP)21Lbe mutation (2 available)
Tg(Pmch-cre)1Lowl mutation (2 available)
Ucp2tm2.1Lowl mutation (1 available); any Ucp2 mutation (41 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
N
• 8-week-old male mutants do not show differences in body weight or daily food intake
• ad libitum-fed and overnight fasted blood glucose levels of 8-week-old male mutants are significantly reduced relative to controls
• during glucose tolerance tests, insulin levels are decreased relative to controls, suggesting that decreased glucose levels are not the result of increased insulin secretion
• 8-week-old males display improved glucose tolerance (after injection of glucose at 2 g/kg body weight), with a significantly reduced rise in blood glucose levels relative to controls
• no alterations in pancreatic beta cells is observed due to ectopic cre expression resulting in Ucp2 deletion in beta cells

nervous system
• about 44% of Pmch neurons fire spontaneously at 5 mM glucose, increased from around 30% of control neurons
• membrane potential of Pmch neurons displays enhanced glucose-induced depolarization in response to different glucose concentrations (left-shifted dose-response curve to glucose)




Genotype
MGI:4887257
cn2
Allelic
Composition
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/?
Tg(Pmch-cre)1Lowl/0
Genetic
Background
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * FVB/NJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Tg(Pmch-cre)1Lowl mutation (2 available)
Ucp2tm2.1Lowl mutation (1 available); any Ucp2 mutation (41 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• 8-week-old males display impaired glucose tolerance (elevated blood glucose at times after injection of glucose at 2 g/kg body weight) compared to control littermates; blood glucose is elevated significantly compared to mice lacking Ucp2 in Pmch neurons or to wild-type controls, indicating that mutant Kcnj11 (Kir6.2) expression blocks glucose-lowering effects of Ucp2 deficiency





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory